$7.54
0.40% (Daily)
Market Cap
$606.90M
Revenue
$27.42M
Rank by MCap
#1336
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Alexandria Forbes Ph.D.
Headquarters
New York, NY
Employees
409
MeiraGTx Holdings plc, a clinical stage genetics medicines company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases; neurodegenerative diseases; and xerostomia. It is also developing AAV-AQP1 in Phase 2 trial for radiation-induced grade 2/3 radiation-induced xerostomia, as well as in Phase ½ trial for Sjogren's syndrome; AAV-GAD in Phase...
Loading chart…